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Abstract 25 
Amidst the COVID-19 pandemic, preprints in the biomedical sciences are being posted and accessed 26 
at unprecedented rates, drawing widespread attention from the general public, press and 27 
policymakers for the first time. This phenomenon has sharpened longstanding questions about the 28 
reliability of information shared prior to journal peer review. Does the information shared in preprints 29 
typically withstand the scrutiny of peer review, or are conclusions likely to change in the version of 30 
record? We assessed preprints that had been posted and subsequently published in a journal between 31 
1st January and 30th April 2020, representing the initial phase of the pandemic response. We utilised a 32 
combination of automatic and manual annotations to quantify how an article changed between the 33 
preprinted and published version. We found that the total number of figure panels and tables changed 34 
little between preprint and published articles. Moreover, the conclusions of 6% of non-COVID-19-35 
related and 15% of COVID-19-related abstracts undergo a discrete change by the time of publication, 36 
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Introduction 48 
Global health and economic development in 2020 were overshadowed by the COVID-19 pandemic, 49 
which grew to over 3.2 million cases and 220,000 deaths within the first four months of the year [1,2]. 50 
[3] The global health emergency created by the pandemic has demanded the production and 51 
dissemination of scientific findings at an unprecedented speed via mechanisms such as preprints, 52 
which are scientific manuscripts posted by their authors to a public server prior to the completion 53 
journal-organised peer review [4]. [5][6]Despite a healthy uptake of preprints by the bioscience 54 
communities in recent years, some concerns persist [8–10]. In particular, one such argument suggests 55 
that preprints are of “lower quality” than peer-reviewed papers. Such concerns have been amplified 56 
during the COVID-19 pandemic, since preprints are being increasingly used to shape policy and 57 
influence public opinion via coverage in social and traditional media [11,12]. One implication of this 58 
hypothesis is that the peer review process will correct many errors and improve reproducibility leading 59 
to significant differences between preprints and published versions. 60 
Several studies have assessed such differences. For example, Klein et al. used quantitative measures 61 
of textual similarity to compare preprints from arXiv and bioRxiv with their published versions [13], 62 
concluding that papers change “very little.” However, changes in the interpretation of a sentence are 63 
not proportional to changes in textual characters (e.g., a major rearrangement of text or figures might 64 
simply represent formatting changes, and vice-versa, the position of a single decimal point could 65 
significantly alter conclusions). Therefore, sophisticated approaches aided or validated by manual 66 
curation are required, as employed by two recent studies. Using preprints and published articles, both 67 
paired and randomised, Carneiro et al. employed manual scoring of methods sections to find modest, 68 
but significant improvements in the quality of reporting among published journal articles [14]. Pagliaro 69 
manually examined the full text of 10 preprints in chemistry, finding only small changes in this sample 70 
[15]. However, the frequency of more significant changes in the conclusions of preprints remained an 71 
open question. We sought to identify an approach that would detect such changes effectively and 72 
without compromising on sample size [13]. We divided our analysis between COVID-19 and non-73 
COVID-19 preprints, as extenuating circumstances such as expedited peer review and increased 74 
attention [FRASER 2020] may impact research related to the pandemic. 75 
To investigate how preprints have changed upon publication, we compared abstracts, figures, and 76 
tables of bioRxiv and medRxiv preprints with their published counterparts to determine the degree to 77 
which the top-line results and conclusions differed between versions. In a detailed analysis of 78 
abstracts, we found that most scientific articles undergo minor changes  without altering the main 79 
conclusions. While this finding should provide confidence in the utility of preprints as a way of rapidly 80 
communicating scientific findings that will largely stand the test of time, the value of subsequent 81 
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manuscript development, including peer review, is underscored by the 6% of non-COVID-19-related  82 
and 15% of COVID-19-related preprints with major changes to their conclusions upon publication. 83 
 84 
Results 85 
COVID-19 preprints were rapidly published during the early phase of the pandemic 86 
The COVID-19 pandemic has spread quickly across the globe, reaching over 3.2 million cases 87 
worldwide within 4 months of the first reported case [1]. The scientific community responded 88 
concomitantly, publishing over 16,000 articles relating to COVID-19 within 4 months [11]. A large 89 
proportion of these articles (>6000) were manuscripts hosted on preprint servers. Following this steep 90 
increase in the posting of COVID-19 research, traditional publishers adapted new policies to support 91 
the ongoing public health emergency response efforts, including efforts to fast-track peer-review of 92 
COVID-19 manuscripts (for example, eLife [16]). At the time of our data collection in May 2020,  4.0% 93 
of COVID-19 preprints were published by the end of April, a statistically significant increase compared 94 
to the 3.0% of non-COVID-19 preprints that were published (Chi-square test; χ2 = 6.77, df = 1, p = 95 
0.009) (Fig. 1A). When broken down by server, 5.3% of COVID-19 preprints hosted on bioRxiv were 96 
published compared to 3.6% of those hosted on medRxiv (Supplemental Fig. 1A). However,  a greater 97 
absolute number of medRxiv vs bioRxiv preprints  (71 vs 30) were included in our sample of detailed 98 
analysis of text changes (see Methods), most likely a reflection of the different focal topics between 99 
the two servers (medRxiv has a greater emphasis on medical and epidemiological preprints, which is 100 
more relevant to the pandemic). 101 
A major concern with expedited publishing is that it may lead to issues of quality and reproducibility 102 
[17]. Assuming that the version of the manuscript originally posted to the preprint server is likely to 103 
be similar to that subjected to peer review, we looked to journal peer review reports to reveal 104 
reviewer perceptions of submitted manuscript quality. We assessed the presence of transparent peer 105 
review (defined as openly available peer review reports published by the journal alongside the article) 106 
and found that an overwhelming majority of preprints that were subsequently published were not 107 
associated with transparent journal reviews (although we did not investigate the availability of non-108 
journal peer review of preprints) (Fig. 1B). The lack of transparent peer reviews was particularly 109 
apparent for research published from medRxiv (Supplemental Fig. 1B). In the absence of peer review 110 
reports, an alternative means of assessing the quality of a scholarly paper is to perform independent 111 
analysis on the underlying data. We therefore investigated the availability of underlying data 112 
associated with preprint-published article pairs. There was little difference in data availability between 113 
the preprint and published version of an article. Additionally, we found no evidence of association 114 
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between overall data availability and COVID-19 status (Fisher’s exact, 1000 simulations; p = 0.383). 115 
However, we note that a greater proportion of COVID-19 articles had a reduction in data availability 116 
when published and vice-versa, a greater proportion of non-COVID-19 articles were more likely to 117 
have additional data available upon publishing (Fig. 1C). This trend was reflected when broken down 118 
by preprint server (Supplemental Fig. 1C). 119 
As the number of authors can give an indication of the amount of work involved, we assessed 120 
authorship changes between the preprint and published articles. Although the vast majority (>75%) 121 
of preprints did not have any changes in authorship when published (Fig. 1D), we found weak evidence 122 
of association between authorship change and COVID-19 status (Fisher’s exact, 1000 simulations; p = 123 
0.047). Specifically, COVID-19 preprints were almost three times as likely to have additional authors 124 
when published compared to non-COVID-19 preprints (14% vs 5%). When this data was broken down 125 
by server, we found that none of the published bioRxiv preprints had any author removals or 126 
alterations in the corresponding author (Supplemental Fig. 1D). 127 
Having examined the properties of preprints that were being published within our timeframe, we next 128 
investigated which journals were publishing these preprints. Among our sample of published 129 
preprints, those describing COVID-19 research were split across many journals, with clinical or 130 
multidisciplinary journals tending to publish the most papers that were previously preprints (Fig. 1E). 131 
Non-COVID-19 preprints were mostly published in PLOS ONE, although they were also found in more 132 
selective journals, such as Cell. When broken down by server, preprints from bioRxiv were published 133 
in a range of journals, including the highly selective Nature and Science (Supplemental Fig. 1E & F); 134 
interestingly, these were all COVID-19 articles.  135 
Together, these data reveal that preprints are published in diverse venues and suggest that during the 136 
early phase of the pandemic, COVID-19 preprints were being expedited through peer review 137 
compared to non-COVID-19 preprints. However, published articles were rarely associated with 138 
transparent peer review and almost 37% of the literature sampled had limited data availability, with 139 
COVID-19 status having little impact on these statistics.  140 
 141 
Figures do not majorly differ between the preprint and published version of an article 142 
One proxy for the total amount of work, or number of experiments, within an article is to quantify the 143 
number of panels in each figure [18]. We therefore quantified the number of panels and tables in each 144 
article in our dataset.  145 
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We found that, on average, there was no difference in the total number of panels and tables between 146 
the preprint and published version of an article. However, COVID-19 articles had fewer total panels 147 
and tables compared to non-COVID-19 articles (Fig. 2A). Moreover, for individual preprint-published 148 
pairs, we found there was a greater variation in the differences in numbers of panels and tables for 149 
COVID-19 articles than non-COVID-19 articles (Fig. 2B). In both cases, preprints posted to bioRxiv 150 
contained a higher number of total panels and tables and greater variation in the difference between 151 
the preprint and published articles than preprints posted to medRxiv (Supplemental Fig. 2A & B). 152 
To further understand the types of panel changes, we classified the changes in panels and tables as 153 
panels being added, removed or rearranged. Independent of COVID-19-status, over 70% of published 154 
preprints were classified with “no change” or superficial rearrangements to panels and tables, 155 
confirming the previous conclusion. Despite this, approximately 20% of articles had “significant 156 
content” added or removed from the figures between preprint and final versions (Fig. 2C). 157 
Surprisingly, none of the preprints posted to bioRxiv experienced removal of content upon publishing 158 
(Supplemental Fig. 2C). 159 
This data suggests that, for most papers in our sample, the individual panels and tables do not majorly 160 
change upon journal publication, suggesting that there are limited new experiments or analyses when 161 
publishing previously posted preprints.   162 
 163 
The majority of abstracts do not discretely change their main conclusions between the 164 
preprint and published article 165 
We compared abstracts between preprints and their published counterparts that had been published 166 
in the first four months of the COVID-19 pandemic (Jan – April 2020). Abstracts contain a summary of 167 
the key results and conclusions of the work and are freely-accessible, they are the most read section. 168 
To computationally identify all individual changes between the preprint and published versions of the 169 
abstract and derive a quantitative measure of similarity between the two, we applied a series of well-170 
established string-based similarity scores, already validated to work for such analyses. We initially 171 
employed the python SequenceMatcher (difflib module), based on the “Gestalt Pattern Matching” 172 
algorithm [19] which determines a change ratio by iteratively aiming to find the longest contiguous 173 
matching subsequence given two pieces of text. We found that COVID-19 abstracts had more changes 174 
than non-COVID-19 abstracts, with a sizeable number appearing to have been drastically re-written 175 
(Fig. 3A). However, one limitation of this method is that it cannot always handle re-arrangements 176 
properly (for example, a sentence moved from the beginning of the abstract to the end) and these are 177 
often counted as changes between the two texts. As a comparison to this open source 178 
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implementation, we employed the output of the Microsoft Word track changes algorithm and used 179 
this as a different type of input for determining the change ratio of two abstracts. Using this method, 180 
we confirmed that abstracts for COVID-19 articles changed more than for non-COVID-19 articles, 181 
although the overall change ratio was significantly reduced (Fig. 3B); this suggests that while at first 182 
look a pair of COVID-19 abstracts may seem very different between their preprint and published 183 
version, most of these changes are due to re-organisation of the content. Nonetheless, the output 184 
obtained by the Microsoft Word track changes algorithm highlights that it is more likely that COVID-185 
19 abstracts undergo larger re-writes (i.e., their score is closer to 1.0). 186 
Since text rearrangements may not result in changes in meaning, four annotators independently 187 
annotated the compared abstracts according to a rubric we developed for this purpose (Table 1, 188 
Supplemental Method 2). We found that independent of COVID-19-status, a sizeable number of 189 
abstracts did not undergo any meaningful changes (24.4% of COVID-19 and 38.7% of non-COVID-19 190 
abstracts). Over 50% of abstracts had  changes that minorly altered, strengthened, or softened the 191 
main conclusions (Fig. 3C, see representative examples in Supplemental Table 2). 15% of COVID-19 192 
abstracts and 6% of non-COVID-19 abstracts had major changes in their conclusions. The main 193 
conclusions of one of these abstracts (representing 0.5% of all abstracts scored) reversed. Excerpts 194 
including each of these major changes are listed in Supplemental Table 3. Using the degree of change, 195 
we evaluated how the manual scoring of abstract changes compared with our automated methods. 196 
We found that the overall change in abstracts was weakly correlated with the difflib change ratio 197 
(Spearman’s rank; ρ = 0.22, p = 0.030 and ρ = 0.39, p < 0.001 for COVID-19 and non-COVID-19 198 
respectively) (Supplemental Fig. 3A) and moderately correlated with the change ratio computed from 199 
Microsoft Word (Spearman’s rank; ρ = 0.56, p < 0.001 and p = 0.52, p < 0.001 for COVID-19 and non-200 
COVID-19 respectively) (Supplemental Fig. 3B).  201 
Among annotations that contributed minorly to the overall change of the abstract, we also annotated 202 
a neutral, positive, or negative direction of change (Table 1, Supplemental method 2). Most of these 203 
changes were neutral, modifying the overall conclusions somewhat without directly strengthening or 204 
softening them (see examples in Supplemental Table 2). Among changes that strengthened or 205 
softened conclusions, we found abstracts that contained only positive changes or only negative 206 
changes, and many abstracts displayed both positive and negative changes (Fig. 3D), in both COVID-207 
19 and non-COVID-19 articles.  When we assessed the sum of positive or negative scores based on the 208 
abstract change degree, we found significant moderate correlations between each score sum (i.e. 209 
number of positive or negative scores) for COVID-19 and non-COVID-19 abstracts and the overall 210 
degree of change (Spearman’s rank; 0.54 < ρ < 0.65 and p < 0.001 in all cases) (Supplemental Fig. 3C).  211 
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We next assessed whether certain subsections of the abstract were more likely to be associated with 212 
changes. The majority of changes within abstracts were associated with results, with a greater 213 
proportion of such annotations for COVID-19 abstracts than non-COVID-19 abstracts (55.3% and 214 
46.6%, respectively (Fig. 3E). We then evaluated the type of change in our annotations, for example 215 
changes to statistical parameters/estimates or addition or removal of information. This demonstrated 216 
that the most frequent changes were additions of new findings to the abstracts following peer review, 217 
followed by removals, which were more common among non-COVID-19 manuscripts (Fig. 3F). We also 218 
frequently found an increase in sample sizes or the use/reporting of statistical tests (type “stat+”) in 219 
the published version of COVID-19 articles compared to their preprints (Supplemental Table 2).  220 
We then investigated whether abstracts with minor or major overall changes more frequently 221 
contained certain types or locations of changes. We found that abstracts with both major and minor 222 
conclusion changes had annotations in all sections, and both degrees of change were also associated 223 
with most types of individual changes. For non-COVID-19 abstracts, 80.7% of our annotated changes 224 
within conclusion sections and 92.2% of our annotated changes within contexts (n = 46 and 118 225 
annotations respectively) belonged to abstracts categorised as having only minor changes 226 
(Supplemental Fig 3D). Moreover, the majority of annotated changes in statistics (between 73% and 227 
96% depending on COVID-status and type of change) were within abstracts with minor changes 228 
(Supplemental Fig. 3E). 229 
Finally, we investigated which journals were publishing preprints from our dataset and if there were 230 
any associations with the scored degree of change (Supplemental Fig. 3F and Supplemental Table 1). 231 
We found that PLOS ONE was the only journal to publish more than one preprint that we determined 232 
to have major changes in the conclusions of the abstract, although this may be a reflection that this 233 
was the journal with the most published non-COVID-19 preprints. Science and Nature published 3 234 
preprints each that we deemed as having minor changes. Three journals published a total of 6 235 
preprints that we scored as having no meaningful changes in their abstracts. It’s important to note 236 
that a number of published preprints appeared in medical journals that did not utilise abstracts and 237 
so were excluded from the analysis of abstract changes. 238 
These data reveal that abstracts of preprints mostly experience minor changes prior to publication. 239 
COVID-19 articles experienced greater alterations than non-COVID-19 preprints and were slightly 240 
more likely to have major alterations to the conclusions. Overall, most abstracts are comparable 241 
between the preprinted and published article.  242 
 243 
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Discussion 244 
With a third of the early COVID-19 literature being shared as preprints [11], we assessed the 245 
differences between these preprints and their subsequently published versions, and compared these 246 
results to a similar sample of non-COVID-19 preprints and their published articles. This enabled us to 247 
provide quantitative evidence regarding the degree of change between preprints and published 248 
articles in the context of the COVID-19 pandemic. We found that preprints were most often passing 249 
into the "permanent" literature with only minor changes to their conclusions, suggesting that the 250 
entire publication pipeline is having a minimal but beneficial effect upon preprints. 251 
The duration of peer review has drastically shortened for COVID-19 manuscripts, although analyses 252 
suggest that these reports are no less thorough [20]. However, in the absence of peer review reports 253 
(Fig. 1B), one method of assessing the “quality” of an article is for interested readers or stakeholders 254 
to re-analyse the data independently. Unfortunately, we found that many authors offered to provide 255 
data only upon request (Fig. 1). Moreover, a number of published articles had faulty hyperlinks that 256 
did not link to the supplemental material. This supports previous findings of limited data sharing in 257 
COVID-19 preprints [21] and faulty web links [22] and enables us to compare trends  to the wider 258 
literature. It is apparent that the ability to thoroughly and independently review the literature and 259 
efforts towards reproducibility are hampered by current data sharing and peer reviewing practices. 260 
Both researchers and publishers must do more to increase reporting and data sharing practices within 261 
the biomedical literature [14,23]. Therefore, we call on journals to embrace open-science practices, 262 
particularly with regards to increased transparency of peer review and data availability. 263 
Abstracts represent the first port of call for most readers, usually being freely available, brief, relatively 264 
jargon-free, and machine-readable. Importantly, abstracts contain the key findings and conclusions 265 
from an article. To analyse differences in abstracts between preprint and paper, we employed multiple 266 
approaches. We first objectively compared textual changes between abstract pairs using a 267 
computational approach before manually annotating abstracts (Fig. 3). Both approaches 268 
demonstrated that COVID-19 articles underwent greater textual changes in their abstracts compared 269 
to non-COVID-19 articles. However, in determining the type of changes, we discovered that 6% of non-270 
COVID-related abstracts and 15% of COVID-related abstracts had discrete, “major” changes in their 271 
conclusions. Indeed, 42% of non-COVID-19 abstracts underwent no meaningful change between 272 
preprint and published versions, though only 34% of COVID-19 abstracts were similarly unchanged. 273 
The majority of changes were “minor” textual alterations that lead to a minor change or strengthening 274 
or softening of conclusions. Of note, about 1/3 of changes were additions of new data (Fig 3F). While 275 
previous works have focused their attention on the automatic processing of many other aspects of 276 
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scientific writing, such as citation analysis [24], topic modelling [25], fact checking [26], and 277 
argumentative analysis [27], we are not aware of formal systemic comparisons between preprints and 278 
published papers that focused on tracking/extracting all changes, with related studies either 279 
producing coarse-grained analyses [13], relying only on derivative resources such as Wikipedia edit 280 
history [46], or utilizing a small sample size and a single reader [15]. Our dataset is a contribution to 281 
the research community that goes beyond the specificities of the topic studied in this work; we hope 282 
it will become a useful resource for the broader scientometrics community to assess the performance 283 
of natural language processing (NLP) approaches developed for the study of fine-grained differences 284 
between preprints and papers. This potential would be amplified if increasing calls for abstracts and 285 
article metadata to be made fully open access were heeded ([23,29] and https://i4oa.org/). 286 
Our findings that abstracts generally underwent few changes was further supported by our analysis 287 
of the figures. The total number of panels and tables did not significantly change between preprint 288 
and paper, independent of COVID-status. However, COVID-19 articles did experience greater variation 289 
in the difference in panel and table numbers compared to non-COVID-19 articles.  290 
While our study provides context for readers looking to understand how preprints may change before 291 
journal publication, we emphasize several limitations. First, we are working with a small sample of 292 
articles that excludes preprints that were unpublished at the time of our analysis. Thus, we have 293 
selected a small minority of COVID-19 articles that were rapidly published, which may not be 294 
representative of those articles which were published more slowly. Moreover, as we were focussing 295 
on the immediate dissemination of scientific findings during a pandemic, our analysis does not 296 
encompass a sufficiently long timeframe to add a reliable control of unpublished preprints. This too 297 
would be an interesting comparison for future study. Indeed, an analysis comparing preprints that are 298 
eventually published with those that never become published would provide stronger and more direct 299 
findings of the role of journal peer review. 300 
Furthermore, our study is not a measure of the changes introduced by the peer review process. A 301 
caveat associated with any analysis comparing preprints to published papers is that it is difficult to 302 
determine when the preprint was posted relative to submission to the journal. The version first posted 303 
to the server may already be in response to one or more rounds of peer review (at the journal that 304 
ultimately publishes the work, or from a previous submission). The changes between the first version 305 
of the preprint (which we analysed) and the final journal publication may result from journal peer 306 
review, comments on the preprint, feedback from colleagues outside of the context of the preprint, 307 
and additional development by the authors independent of these sources.  308 
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Although we did not try to precisely determine the number of experiments (i.e. by noting how many 309 
panels or tables were from a single experimental procedure), this is an interesting area of future work 310 
that we aim to pursue. 311 
One of the key limitations of our data is the difficulty in objectively comparing two versions of a 312 
manuscript. Our approach revealed that computational approaches comparing textual changes at 313 
string-level are insufficient for revealing the true extent of change. For example, we discovered 314 
abstracts that contained many textual changes (such as rearrangements) that did not impact on the 315 
conclusions and were scored by annotators as having no meaningful changes. In contrast, some 316 
abstracts that underwent major changes as scored by annotators were found to have very few textual 317 
changes. This demonstrates the necessity that future studies will focus on more semantic natural 318 
language processing approaches when comparing manuscripts that go beyond shallow differences 319 
between strings of texts [30]. Nevertheless, the difficulty when dealing with such complex semantic 320 
phenomena is that different assessors may annotate changes differently. We attempted to develop a 321 
robust set of annotation guidelines to limit the impact of this. Our strategy was largely successful, but 322 
we propose a number of changes for future implementation. We suggest simplifying the categories 323 
(which would reduce the number of conflicting annotations) and conducting robust assessments of 324 
inter-annotator consistency. To do this, we recommend that a training set of data are utilised before 325 
assessors annotate independently. While this strategy is more time-consuming (due to the fact that 326 
annotator might need several training trials before reaching a satisfying agreement), in the long-run 327 
it is a more scalable strategy as there will be no need of a meta-annotator double-checking all 328 
annotations against the guidelines, as we had in our work.   329 
Our data analysing abstracts suggests that the main conclusions of 94% of non-COVID-related life 330 
sciences articles do not change from their preprint to final published versions, with only one out of 331 
185 papers in our analysis reversing the conclusion made by its preprint. This data supports the usual 332 
caveats that researchers should perform their own peer review any time they read an article, whether 333 
it is a preprint or published paper. Moreover, our data provides confidence in the use of preprints for 334 
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Preprint metadata for bioRxiv and medRxiv 339 
Our preprint dataset is derived from the same dataset presented in version 1 of Fraser et al [11]. In 340 
brief terms, bioRxiv and medRxiv preprint metadata (DOIs, titles, abstracts, author names, 341 
corresponding author name and institution, dates, versions, licenses, categories and published article 342 
links) were obtained via the bioRxiv Application Programming Interface (API; https://api.biorxiv.org). 343 
The API accepts a ‘server’ parameter to enable retrieval of records for both bioRxiv and medRxiv. 344 
Metadata was collected for preprints posted 1st January 2020 - 30th April 2020 (N = 14,812). All data 345 
were collected on 1st May 2020. Note that where multiple preprint versions existed, we included only 346 
the earliest version and recorded the total number of following revisions. Preprints were classified as 347 
“COVID-19 preprints” or “Non-COVID-19 preprints” on the basis of the following terms contained 348 
within their titles or abstracts (case-insensitive): “coronavirus”, “covid-19”, “sars-cov”, “ncov-2019”, 349 
“2019-ncov”, “hcov-19”, “sars-2”. 350 
 351 
Comparisons of figures and tables between preprints and their published articles 352 
We identified COVID-19 bioRxiv and medRxiv preprints that have been subsequently published as peer 353 
reviewed journal articles (based on publication links provided directly by bioRxiv and medRxiv in the 354 
preprint metadata derived from the API) resulting in a set of 105 preprint-paper pairs. We generated 355 
a control set of 105 non-COVID-19 preprint-paper pairs by drawing a random subset of all bioRxiv and 356 
medRxiv preprints published in peer reviewed journals, extending the sampling period to 1st 357 
September 2019 - 30th April 2020 in order to preserve the same ratio of bioRxiv:medRxiv preprints as 358 
in the COVID-19 set. Links to published articles are likely an underestimate of the total proportion of 359 
articles that have been subsequently published in journals – both as a result of the delay between 360 
articles being published in a journal and being detected by preprint servers, and preprint servers 361 
missing some links to published articles when e.g., titles change significantly between the preprint and 362 
published version [31]. Detailed published article metadata (titles, abstracts, publication dates, journal 363 
and publisher name) were retrieved by querying each DOI against the Crossref API 364 
(https://api.crossref.org), using the rcrossref package for R [32]. 365 
Each preprint-paper pair was then scored independently by two referees using a variety of 366 
quantitative and qualitative metrics reporting on changes in data presentation and organisation, the 367 
quantity of data, and the communication of quantitative and qualitative outcomes between paper and 368 
preprint (using the reporting questionnaire; Supplemental Methods 1). Of particular note: individual 369 
figure panels were counted as such when labelled with a letter, and for pooled analyses a full table 370 
was treated as a single-panel figure. The number of figures and figure panels was capped at 10 each 371 
(any additional figures/panels were pooled), and the number of supplementary items 372 
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(files/figures/documents) were capped at 5. In the case of preprints with multiple versions, the 373 
comparison was always restricted to version 1, i.e., the earliest version of the preprint. Any conflicting 374 
assessments were resolved by a third independent referee, resulting in a final consensus report for 99 375 
non-COVID-19 and 101 COVID-19 preprint-paper pairs (excluding 10 pairs not meeting the initial 376 
selection criteria or those still awaiting post-publication reviews).  377 
 378 
Annotating changes in abstracts 379 
In order to prepare our set of 200 abstracts for analysis of their abstracts, where abstract text was not 380 
available via the Crossref API, we manually copied it into the datasheet. To identify all individual 381 
changes between the preprint and published versions of the abstract and derive a quantitative 382 
measure of similarity between the two, we applied a series of well-established string-based similarity 383 
scores, already tested for this type of analyses: (1) the python SequenceMatcher, based on the 384 
“Gestalt Pattern Matching” algorithm [19], determines a change ratio by iteratively aiming to find 385 
longest contiguous matching subsequence given two pieces of text; (2) as a comparison to this open 386 
source implementation, we employed the output of the Microsoft Word track changes algorithm (see 387 
details in Supplemental Method 3), and used this as a different type of input for determining the 388 
change ratio of two abstracts. Employing the output of (2), which consisted in a series of highlighted 389 
changes for each abstract-pair, four co-authors annotated each abstract, based on a predefined set of 390 
labels and guidelines (Table 1, Supplemental Method 2). Each annotation contained information about 391 
the section of the abstract, the type of change that had occurred, and the degree to which this change 392 
impacted the overall message of the abstract. Changes (such as formatting, stylistic edits, or text 393 
rearrangements) without meaningful impact on the conclusions were not annotated. We then 394 
manually categorised each abstract based on its highest degree of annotation: “no change” containing 395 
no annotations, “strengthening/softening, minor” containing only 1, 1-, or 1+, or “major conclusions 396 
change” containing either a 2 or a 3, since only a single abstract contained a 3.  See supplementary 397 
tables 2 and 3 for a list of representative annotations for each type and all annotations that resulted 398 
in major conclusions change. The final set of annotations was produced by one of the authors, who 399 
assigned each final label by taking into account the majority position across annotators, their related 400 
comments and consistency with the guidelines.  401 
 402 
Table 1. Tags (one each of section, type, and degree) applied to each annotation of text 403 
meaningfully changed in abstracts. 404 
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Section Description 
context Background or methods 
results A statement linked directly to data 
conclusion Interpretations and/or implications 
Type Description 
added New assertion 
removed Assertion removed 
nounchange One noun is substituted for another (“fever” becomes “high fever”) 
effectreverse The opposite assertion is now being made (word “negatively” added) 
effect+ The effect is now stronger (changes in verbs/adjectives/adverbs) 
effect- The effect is now weaker (changes in verbs/adjectives/adverbs) 
stat+ Statistical significance increased (expressed as number or in words) 
stat- Statistical significance decreased (expressed as number or in words) 
statinfo Addition/removal of statistical information (like a new test or confidence 
intervals) 
Degree Description 
1  Significant: minorly alters a main conclusion of the paper 
1-  Significant: softens a main conclusion of the paper 
1+ Significant: strengthens a main conclusion of the paper 
2 Major: a discrete change in a main conclusion of the paper 
3 Massive: a main conclusion of the paper reversed 
 405 
Statistical analyses  406 
Categorical traits of preprints or annotations (e.g. COVID-19 or non-COVID-19; type of change) were 407 
compared by calculating contingency tables and using Chi-square tests or Fisher’s exact tests using 408 
Monte Carlo simulation in cases where any expected values were < 5. Quantitative preprint traits (e.g. 409 
change ratios) were correlated with other quantitative traits using Spearman’s rank tests.  410 
 411 
Parameters and limitations of this study 412 
We acknowledge a number of limitations in our study. Firstly, to assign a preprint as COVID-19 or not, 413 
we used keyword matching to titles/abstracts on the preprint version at the time of our data 414 
extraction. This means we may have captured some early preprints, posted before the pandemic, that 415 
had been subtly revised to include a keyword relating to COVID-19. Our data collection period was a 416 
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tightly defined window (January-April 2020) meaning that our data suffers from survivorship and 417 
selection bias in that we could only examine preprints that have been published and our findings may 418 
not be generalisable to all preprints. A larger, more comprehensive sample would be necessary for 419 
more conclusive conclusions to be made. 420 
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Figures 530 
531 
Figure 1. Publishing and peer-review of preprints during the COVID-19 pandemic. (A) percentage of 532 
COVID-19 and non-COVID-19 preprints published between Jan-April 2020. (B) Percentage of published 533 
preprints associated with transparent peer review (the publication of review reports with the journal 534 
version of the article). (C) Data availability after publication. (D) Change in authorship after publication. 535 
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(E) Journals that are publishing preprints. Panel (A) describes all available data (n = 14,812 preprints), 536 
while panels (B) – (E) describe sample of preprints analysed in detail (n = 200).  537 
  538 
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 539 
Figure 2. Preprint-publication pairs do not significantly differ in the total numbers of panels and 540 
tables. (A) Total numbers of panels and tables in preprints and published articles. (B) Difference in the 541 
total number of panels and tables between the preprint and published versions of articles. (C) 542 
Subjective classification of figure changes between preprint and published articles. All panels describe 543 
sample of preprints analysed in detail (n = 200). 544 
 545 
  546 
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 547 
Figure 3. Preprint-publication abstract pairs are not significantly different. (A) Difflib calculated 548 
change ratio for COVID-19 or non-COVID-19 abstracts. (B) Change ratio calculated from Microsoft 549 
Word for COVID-19 or non-COVID-19 abstracts. (C) Overall changes in abstracts for COVID-19 or non-550 
COVID-19 abstracts. (D) Sum of positive and negative annotations for COVID-19 or non-COVID-19 551 
abstracts. (E) Location of annotations within COVID-19 or non-COVID-19 abstracts. (F) Type of 552 
annotated change within COVID-19 or non-COVID-19 abstracts. All panels describe sample of abstracts 553 
analysed in detail (n = 185). 554 
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Supplemental Figure 1. Publishing and peer-review of preprints during the COVID-19 pandemic 558 
broken down by server. (A) Percentage of COVID-19 and non-COVID-19 preprints published between 559 
Jan-April 2020. (B) Published preprints associated with transparent peer-review. (C) Data availability 560 
for published preprints. (D) Change in authorship for published preprints. (E) Journals that are 561 
publishing bioRxiv preprints. (F) Journals that are publishing medRxiv preprints.  562 
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 564 
Supplemental Figure 2. Preprint-publication pairs do not significantly differ in the total numbers of 565 
panels and tables as broken down by server. (A) Total numbers of panels and tables in preprints and 566 
published articles. (B) Difference in the total number of panels and tables between the preprint and 567 
published versions of articles. (C) Classification of figure changes between preprint and published 568 
articles.  569 
 570 
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 571 
Supplemental Figure 3. Granular annotations of changes in abstracts in context of the overall 572 
change. (A) Difflib calculated change ratio for COVID-19 or non-COVID-19 abstracts, based on the 573 
overall abstract change. (B) Change ratio calculated from Microsoft Word for COVID-19 or non-COVID-574 
19 abstracts, based on the overall abstract change. (C) Sum of positive and negative annotations for 575 
COVID-19 or non-COVID-19 abstracts, based on the overall abstract change. (D) Percentage of 576 
annotations in each location within COVID-19 or non-COVID-19 abstracts, based on the overall 577 
abstract change. Labels denote absolute number of annotations. (E) Percentage of annotations of each 578 
type within COVID-19 or non-COVID-19 abstracts, based on the overall abstract change. Labels denote 579 
absolute number of annotations. (F) Journals publishing COVID-19 preprints, based on overall abstract 580 
changes. Data labels: AAaC: Antimicrobial Agents and Chemotherapy, AJoCP: American Journal of 581 
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Clinical Pathology, AoIM: Archives of Iranian Medicine, AotRD: Annals of the Rheumatic Diseases, 582 
APSB: Acta Pharmaceutica Sinica B, BaBRC: Biochemical and Biophysical Research Communications, 583 
BBaI: Brain, Behavior, and Immunity, BMJ: BMJ, Bnfr: Bioinformatics, CCaLM(: Clinical Chemistry and 584 
Laboratory Medicine (CCLM), Cell: Cell, CGaH: Clinical Gastroenterology and Hepatology, CJoA: 585 
Canadian Journal of Anesthesia, ClID: Clinical Infectious Diseases, CllR: Cell Research, ClnI: Clinical 586 
Immunology, CMaI: Clinical Microbiology and Infection, EBMd: EBioMedicine, EClM: 587 
EClinicalMedicine, EM&I: Emerging Microbes & Infections, EmID: Emerging Infectious Diseases, ErRJ: 588 
European Respiratory Journal, Ersr: Eurosurveillance, EvlA: Evolutionary Applications, Gstr: 589 
Gastroenterology, IaORV: Influenza and Other Respiratory Viruses, IGaE: Infection, Genetics and 590 
Evolution, IJoAA: International Journal of Antimicrobial Agents, IJoID: International Journal of 591 
Infectious Diseases, InDM: Infectious Disease Modelling, IPiP: Infection Prevention in Practice, JoCaTS: 592 
Journal of Clinical and Translational Science, JoHI: Journal of Hospital Infection, JoMIR: Journal of 593 
Medical Internet Research, JoMV: Journal of Medical Virology, JrnlofClnclMc: Journal of Clinical 594 
Microbiology, JrnlofClnclMd: Journal of Clinical Medicine, JroI: Journal of Infection, JroV: Journal of 595 
Virology, MBaE: Mathematical Biosciences and Engineering, MMoNP: Mathematical Modelling of 596 
Natural Phenomena, Natr: Nature, NEJoM: New England Journal of Medicine, NtrMc: Nature 597 
Microbiology, NtrMd: Nature Medicine, OPHaRP: Osong Public Health and Research Perspectives, 598 
PblH: Public Health, PLOO: PLOS ONE, PotNAoS: Proceedings of the National Academy of Sciences, 599 
PrtS: Protein Science, PsyR: Psychiatry Research, QAIJoM: QJM: An International Journal of Medicine, 600 
QntB: Quantitative Biology, RspR: Respiratory Research, SCLS: Science China Life Sciences, Scnc: 601 
Science, SoTTE: Science of The Total Environment, STaTT: Signal Transduction and Targeted Therapy, 602 
SwMW: Swiss Medical Weekly, TAJoEM: The American Journal of Emergency Medicine, ThLM: The 603 
Lancet Microbe, TJoID: The Journal of Infectious Diseases, TJoMD: The Journal of Molecular 604 
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